Akanda (AKAN) Revenue & Revenue Breakdown
Akanda Revenue Highlights
Latest Revenue (Y)
$2.16M
Latest Revenue (Q)
$762.61K
Akanda Revenue by Period
Akanda Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $2.16M | -17.55% |
2022-12-31 | $2.62M | 6223.00% |
2021-12-31 | $41.43K | 1909.26% |
2020-12-31 | $2.06K | 100.00% |
2019-12-31 | - | - |
Akanda Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2023-12-31 | $762.61K | 100.00% |
2023-09-30 | $381.30K | -72.71% |
2023-06-30 | $1.40M | 100.00% |
2023-03-31 | $698.72K | -72.56% |
2022-12-31 | $2.55M | 100.00% |
2022-09-30 | $1.27M | 1641.95% |
2022-06-30 | $73.10K | 203.66% |
2021-12-31 | $24.07K | 79.32% |
2021-09-30 | $13.42K | 4799.27% |
2020-12-31 | $274.00 | - |
Akanda Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
PTPI | Petros Pharmaceuticals | $5.82B | $1.42M |
LFCR | Lifecore Biomedical | $128.26M | $24.70M |
ACOR | Acorda Therapeutics | $102.42M | $20.29M |
DERM | Journey Medical | $79.18M | $14.86M |
BFRI | Biofrontera | $34.01M | $7.83M |
UPC | Universe Pharmaceuticals | $32.31M | $13.84M |
SNOA | Sonoma Pharmaceuticals | $12.73M | $3.39M |
GHSI | Guardion Health Sciences | $12.25M | $36.35K |
AKAN | Akanda | $2.16M | $762.61K |
SXTC | China SXT Pharmaceuticals | $1.97M | $939.58K |
LSDI | Lucy Scientific Discovery | $7.05K | $9.68K |
SHPH | Shuttle Pharmaceuticals | - | - |